News UK 'needs more transparency on pharma-doctor payments' The UK's system of disclosing payments from pharma to healthcare professionals has gaps that hide potential conflicts of interest, claims study.
News Payments from UK pharma to healthcare professionals increase... The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face